Valuation: Orion Oyj

Market Cap 11.59B 13.16B 10.98B 9.92B 18.69B 1,262B 18.93B 131B 50.57B 645B 49.43B 48.35B 2,069B P/E 2026 *
20.5x
P/E 2027 * 17.4x
Enterprise Value 11.5B 13.06B 10.9B 9.84B 18.54B 1,252B 18.78B 130B 50.18B 640B 49.05B 47.98B 2,053B EV / Sales 2026 *
5.49x
EV / Sales 2027 * 4.74x
Free-Float
90.5%
Yield 2026 *
2.36%
Yield 2027 * 2.63%
1 day+0.49%
1 week+0.61%
Current month+5.06%
1 month+5.06%
3 months+15.50%
6 months+22.21%
Current year+30.56%
1 week 81.4
Extreme 81.4
84.6
1 month 78
Extreme 78
84.6
Current year 62.7
Extreme 62.7
84.6
1 year 56.5
Extreme 56.5
84.6
3 years 31.86
Extreme 31.86
84.6
5 years 31.86
Extreme 31.86
84.6
10 years 22.57
Extreme 22.57
84.6
Manager TitleAgeSince
Chief Executive Officer 59 31/10/2022
Director of Finance/CFO 50 30/04/2024
Chief Operating Officer 46 31/12/2021
Director TitleAgeSince
Director/Board Member 63 21/03/2017
Director/Board Member 65 21/03/2017
Director/Board Member 66 05/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
08/08/25 Sell

Chief Operating Officer

4,000 0.0122%
04/08/25 Sell

Executive/Senior Manager

71 0.0002%
04/08/25 Sell

Executive/Senior Manager

724 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
+0.85%+0.61%+27.55%+119.96% 13.14B
-1.71%+1.51%+53.13%+117.05% 1,056B
-0.76%-1.21%+43.42%+71.40% 645B
-0.12%-0.73%+13.65%+77.50% 465B
-2.12%-1.42%+73.92%+42.34% 368B
-0.06%-3.88%+34.32%+40.74% 335B
-0.79%+2.01%+19.82%+28.48% 275B
-1.19%-1.21%+9.82%+12.15% 255B
-0.36%+3.83%+49.42%+58.33% 229B
-0.98%-0.79%+35.30%+102.67% 188B
Average -0.72%-0.09%+36.03%+67.06% 382.89B
Weighted average by Cap. -1.02%+0.29%+40.59%+73.14%

Financials

2026 *2027 *
Net sales 2.1B 2.38B 1.99B 1.79B 3.38B 228B 3.42B 23.77B 9.15B 117B 8.94B 8.75B 374B 2.37B 2.69B 2.25B 2.03B 3.83B 258B 3.88B 26.9B 10.35B 132B 10.12B 9.9B 423B
Net income 566M 642M 536M 484M 912M 61.58B 924M 6.41B 2.47B 31.48B 2.41B 2.36B 101B 668M 759M 633M 571M 1.08B 72.73B 1.09B 7.57B 2.91B 37.18B 2.85B 2.79B 119B
Net Debt -89.76M -102M -85.04M -76.78M -145M -9.77B -147M -1.02B -392M -5B -383M -374M -16.02B -333M -378M -315M -285M -537M -36.25B -544M -3.77B -1.45B -18.53B -1.42B -1.39B -59.42B
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,000
Date Price Change Volume
30/09/26 €83.10 +0.85% 174,770
29/09/26 €82.40 -1.90% 136,674
28/09/26 €84.00 +1.27% 144,797
25/09/26 €82.95 +0.06% 106,588
24/09/26 €82.90 +0.36% 120,727
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
82.40EUR
Average target price
76.67EUR
Spread / Average Target
-6.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ORNBV Stock